ArticleEULAR rheumatology open2025
Altered somatosensory profiles in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic sclerosis.
Article in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This exploratory study aimed to examine the somatosensory profiles of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), and systemic sclerosis (SSc) using quantitative sensory testing (QST). We sought to identify distinct patterns of sensory alterations to enhance the understanding of pain mechanisms in these conditions and to generate hypotheses for future mechanistic research and therapy approaches. Methods: Patients with RA, PsA, axSpA, and SSc underwent QST on both hands to evaluate all somatosensory submodalities. Standardised assessment, following the German Research Network on Neuropathic Pain protocol, included mechanical detection threshold (MDT) and vibration detection threshold (VDT) as well as thermal detection and pain thresholds. Results: We enrolled 80 patients (20 with RA, PsA, axSpA, SSc) and 20 controls. Significant differences in MDT (RA: Conclusions: Patients with RA, PsA, axSpA, and SSc demonstrate significant alterations in somatosensory processing, including abnormal MDT and VDT, and pathological allodynia that appear independent of inflamed areas. These sensory changes do not correlate with disease activity, duration, inflammatory markers, or therapeutic approach, indicating that they may result from mechanisms distinct from inflammation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.